1,2-dichloroethane increases expression EXP 6480464 ethylene dichloride results in increased expression of WNT10B mRNA CTD PMID:28960355 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression EXP 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in decreased expression of WNT10B mRNA CTD PMID:12021203 17beta-estradiol multiple interactions EXP 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of WNT10B mRNA] CTD PMID:25210133 17beta-estradiol increases expression ISO RGD:1312744 6480464 Estradiol results in increased expression of WNT10B mRNA CTD PMID:12437293 more ... 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of WNT10B mRNA CTD PMID:25210133 17beta-estradiol 3-benzoate increases expression ISO RGD:1304988 6480464 estradiol 3-benzoate results in increased expression of WNT10B mRNA CTD PMID:27415467 17beta-estradiol 3-benzoate decreases methylation ISO RGD:1304988 6480464 estradiol 3-benzoate results in decreased methylation of WNT10B promoter CTD PMID:27415467 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to WNT10B promoter] CTD PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of WNT10B mRNA CTD PMID:21570461 3,7-dihydropurine-6-thione decreases expression ISO RGD:1304988 6480464 Mercaptopurine results in decreased expression of WNT10B mRNA CTD PMID:23358152 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B mRNA, APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B protein] CTD PMID:28242765 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1312744 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of WNT10B gene CTD PMID:31601247 5-azacytidine increases expression ISO RGD:1304988 6480464 Azacitidine results in increased expression of WNT10B mRNA CTD PMID:27415467 5-formyltetrahydrofolic acid multiple interactions ISO RGD:1304988 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of WNT10B mRNA CTD PMID:25187349 6-propyl-2-thiouracil decreases expression ISO RGD:1304988 6480464 Propylthiouracil results in decreased expression of WNT10B mRNA CTD PMID:24780913 aflatoxin B1 increases expression ISO RGD:1312744 6480464 Aflatoxin B1 results in increased expression of WNT10B mRNA CTD PMID:22100608 all-trans-retinoic acid decreases expression ISO RGD:1312744 6480464 Tretinoin results in decreased expression of WNT10B mRNA CTD PMID:33167477 allethrin increases expression ISO RGD:1312744 6480464 Allethrins results in increased expression of WNT10B mRNA CTD PMID:12437293 atrazine affects methylation ISO RGD:1304988 6480464 Atrazine affects the methylation of WNT10B gene CTD PMID:28931070 benzo[a]pyrene decreases methylation ISO RGD:1312744 6480464 Benzo(a)pyrene results in decreased methylation of WNT10B promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1312744 6480464 Benzo(a)pyrene results in increased expression of WNT10B mRNA CTD PMID:32234424 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1312744 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene decreases expression EXP 6480464 benzo(b)fluoranthene results in decreased expression of WNT10B mRNA CTD PMID:26377693 Benzo[k]fluoranthene decreases expression EXP 6480464 benzo(k)fluoranthene results in decreased expression of WNT10B mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1304988 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of WNT10B promoter CTD PMID:23359474 bisphenol A multiple interactions ISO RGD:1304988 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of WNT10B promoter CTD PMID:23359474 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of WNT10B mRNA CTD PMID:30951980 , PMID:32156529 bisphenol A increases methylation ISO RGD:1304988 6480464 bisphenol A results in increased methylation of WNT10B gene CTD PMID:28505145 bisphenol A affects expression ISO RGD:1304988 6480464 bisphenol A affects the expression of WNT10B mRNA CTD PMID:25181051 bisphenol F decreases expression EXP 6480464 bisphenol F results in decreased expression of WNT10B mRNA CTD PMID:30951980 butanal increases expression ISO RGD:1312744 6480464 butyraldehyde results in increased expression of WNT10B mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:1312744 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT10B mRNA CTD PMID:35301059 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of WNT10B mRNA CTD PMID:19818801 cadmium dichloride multiple interactions ISO RGD:1312744 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of WNT10B mRNA CTD PMID:35301059 carbamazepine affects expression ISO RGD:1312744 6480464 Carbamazepine affects the expression of WNT10B mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 chlorpyrifos affects expression ISO RGD:1304988 6480464 Chlorpyrifos affects the expression of WNT10B mRNA CTD PMID:18502319 cisplatin increases expression ISO RGD:1312744 6480464 Cisplatin results in increased expression of WNT10B mRNA CTD PMID:27392435 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of WNT10B mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of WNT10B mRNA] CTD PMID:17585979 copper atom multiple interactions ISO RGD:1312744 6480464 [Chelating Agents binds to Copper] which results in decreased expression of WNT10B mRNA, [NSC 689534 binds to Copper] which results in decreased expression of WNT10B mRNA CTD PMID:20971185 , PMID:30911355 copper(0) multiple interactions ISO RGD:1312744 6480464 [Chelating Agents binds to Copper] which results in decreased expression of WNT10B mRNA, [NSC 689534 binds to Copper] which results in decreased expression of WNT10B mRNA CTD PMID:20971185 , PMID:30911355 Cuprizon decreases expression ISO RGD:1304988 6480464 Cuprizone results in decreased expression of WNT10B mRNA CTD PMID:26577399 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B mRNA, APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in decreased expression of WNT10B protein] CTD PMID:28242765 dibutyl phthalate multiple interactions ISO RGD:1304988 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of WNT10B promoter CTD PMID:23359474 diosgenin decreases expression EXP 6480464 Diosgenin results in decreased expression of WNT10B mRNA CTD PMID:26408789 dorsomorphin multiple interactions ISO RGD:1312744 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT10B mRNA CTD PMID:27188386 fenvalerate increases expression ISO RGD:1312744 6480464 fenvalerate results in increased expression of WNT10B mRNA CTD PMID:12437293 genistein decreases expression ISO RGD:1304988 6480464 Genistein results in decreased expression of WNT10B mRNA CTD PMID:24361872 genistein increases methylation ISO RGD:1304988 6480464 Genistein results in increased methylation of WNT10B promoter CTD PMID:24361872 lead(0) affects expression ISO RGD:1312744 6480464 Lead affects the expression of WNT10B mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1312744 6480464 Lead affects the expression of WNT10B mRNA CTD PMID:28903495 linoleic acid decreases expression EXP 6480464 Linoleic Acid results in decreased expression of WNT10B mRNA CTD PMID:12021203 manganese(II) chloride decreases expression ISO RGD:1304988 6480464 manganese chloride results in decreased expression of WNT10B mRNA CTD PMID:28801915 mercaptopurine decreases expression ISO RGD:1304988 6480464 Mercaptopurine results in decreased expression of WNT10B mRNA CTD PMID:23358152 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of WNT10B mRNA CTD PMID:18502557 methotrexate multiple interactions ISO RGD:1304988 6480464 [Methotrexate co-treated with Leucovorin] results in increased expression of WNT10B mRNA CTD PMID:25187349 N-Nitrosopyrrolidine increases expression ISO RGD:1312744 6480464 N-Nitrosopyrrolidine results in increased expression of WNT10B mRNA CTD PMID:32234424 O-methyleugenol increases expression ISO RGD:1312744 6480464 methyleugenol results in increased expression of WNT10B mRNA CTD PMID:32234424 panobinostat multiple interactions ISO RGD:1312744 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT10B mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1312744 6480464 panobinostat results in increased expression of WNT10B mRNA CTD PMID:26272509 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of WNT10B mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of WNT10B mRNA] CTD PMID:17585979 perfluorohexanesulfonic acid decreases expression ISO RGD:1312744 6480464 perfluorohexanesulfonic acid results in decreased expression of WNT10B mRNA CTD PMID:25812627 perfluorononanoic acid decreases expression ISO RGD:1312744 6480464 perfluoro-n-nonanoic acid results in decreased expression of WNT10B mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1312744 6480464 perfluorooctane sulfonic acid results in decreased expression of WNT10B mRNA CTD PMID:25812627 perfluorooctanoic acid decreases expression ISO RGD:1312744 6480464 perfluorooctanoic acid results in decreased expression of WNT10B mRNA CTD PMID:25812627 permethrin increases expression ISO RGD:1312744 6480464 Permethrin results in increased expression of WNT10B mRNA CTD PMID:12437293 phenothrin increases expression ISO RGD:1312744 6480464 phenothrin results in increased expression of WNT10B mRNA CTD PMID:12437293 purine-6-thiol decreases expression ISO RGD:1304988 6480464 Mercaptopurine results in decreased expression of WNT10B mRNA CTD PMID:23358152 resveratrol multiple interactions EXP 6480464 [Dietary Fats co-treated with Resveratrol] results in increased expression of WNT10B mRNA CTD PMID:29197120 SB 431542 multiple interactions ISO RGD:1312744 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of WNT10B mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1312744 6480464 Silicon Dioxide analog results in increased expression of WNT10B mRNA CTD PMID:25895662 sodium fluoride multiple interactions EXP 6480464 PTH protein promotes the reaction [Sodium Fluoride results in increased expression of WNT10B mRNA], Sodium Fluoride affects the reaction [PTH protein results in increased expression of WNT10B mRNA] CTD PMID:29447955 sodium fluoride multiple interactions ISO RGD:1304988 6480464 PTH protein promotes the reaction [Sodium Fluoride results in increased expression of WNT10B mRNA] CTD PMID:29447955 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of WNT10B mRNA CTD PMID:29447955 sotorasib multiple interactions ISO RGD:1312744 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of WNT10B mRNA CTD PMID:36139627 tamoxifen decreases expression ISO RGD:1312744 6480464 Tamoxifen results in decreased expression of WNT10B mRNA CTD PMID:15590111 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of WNT10B mRNA CTD PMID:29264374 trametinib multiple interactions ISO RGD:1312744 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of WNT10B mRNA CTD PMID:36139627 trichostatin A increases expression ISO RGD:1312744 6480464 trichostatin A results in increased expression of WNT10B mRNA CTD PMID:24935251 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of WNT10B mRNA CTD PMID:17292431 zinc atom multiple interactions EXP 6480464 [Zinc deficiency promotes the reaction [TRP53 gene mutant form results in increased susceptibility to nitrosobenzylmethylamine]] which results in decreased expression of WNT10B mRNA CTD PMID:12517797 zinc(0) multiple interactions EXP 6480464 [Zinc deficiency promotes the reaction [TRP53 gene mutant form results in increased susceptibility to nitrosobenzylmethylamine]] which results in decreased expression of WNT10B mRNA CTD PMID:12517797